NSE · AAREYDRUGS
Aarey Drugs & Pharmaceuticals Limited
Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.
Market cap rank
#2,231
of 5,072 stocks
▲ 21W
Peak #2,231 · 27 Sep 2026
A microcap name in Healthcare, Aarey Drugs & Pharmaceuticals Limited carries a steep earnings multiple that prices in strong future growth, has a subdued return on equity, and is seeing revenue slip.
Market Cap
289.01 Cr
P/E Ratio
73.07
P/B Ratio
1.92
ROE
2.64%
ROCE
6.84%
Dividend Yield
—
52W High
—
52W Low
—
Quarterly financials
| Metric | Q1 2026-27 | Q4 2025-26 | Q3 2025-26 | Q2 2025-26 |
|---|---|---|---|---|
| Revenue | 44.63 Cr | 189.47 Cr | 96.43 Cr | 84.16 Cr |
| Net Profit | 1.02 Cr | 1.56 Cr | 56.95 L | 1.02 Cr |
| EPS | 0.36 | 0.55 | 0.20 | 0.72 |
| Operating Profit | 2.19 Cr | 3.06 Cr | 1.84 Cr | 2.74 Cr |
Shareholding pattern
Promoter
37.71%
Public
62.29%
Mutual fund holdings
Mutual fund holdings data for this stock hasn't been ingested yet — check back soon.
Recent corporate actions
| Ex-Date | Type | Details |
|---|---|---|
| 23 Sep 2024 | Other | Annual General Meeting |
| 29 Aug 2023 | Other | Annual General Meeting |
| 22 Sep 2022 | Other | Annual General Meeting |
| 02 Sep 2021 | Other | Annual General Meeting |
Need this data in your app?
Full price history, technical indicators, and every field above via one REST API call.